Huib N Caron Selected Research

Huib N Caron Research Topics

Disease

52	Neoplasms (Cancer) 01/2023 - 03/2002
46	Neuroblastoma 01/2023 - 03/2002
16	Cardiotoxicity 11/2015 - 07/2004
9	Heart Failure 11/2015 - 10/2006
7	Rhabdomyosarcoma 10/2017 - 01/2009
6	Residual Neoplasm 01/2019 - 11/2008
3	Infections 01/2016 - 09/2009
3	Thoracic Neoplasms 01/2015 - 03/2010
3	Sarcoma (Soft Tissue Sarcoma) 09/2014 - 01/2009
3	Ewing Sarcoma (Sarcoma, Ewing) 09/2014 - 01/2009
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2014 - 01/2009
2	Medulloblastoma 01/2016 - 08/2008
2	Dizziness (Lightheadedness) 09/2015 - 09/2011
2	Sepsis (Septicemia) 09/2015 - 08/2013
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2015 - 10/2013
2	Hepatoblastoma 09/2014 - 01/2011
2	Wilms Tumor (Wilm's Tumor) 10/2010 - 10/2009
2	Neutropenia 10/2009 - 09/2009
1	Hearing Loss (Hearing Impairment) 01/2022
1	Ototoxicity 01/2022
1	Congenital Abnormalities (Deformity) 10/2017
1	Facial Asymmetry 10/2017
1	Cerebral Infarction 11/2016
1	Cerebral Hemorrhage 11/2016
1	Stroke (Strokes) 11/2016
1	Transient Ischemic Attack 11/2016
1	Carcinogenesis 05/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2016
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2016
1	Febrile Neutropenia 01/2016
1	Osteosarcoma (Osteogenic Sarcoma) 01/2016
1	Leukemia 01/2016
1	Retinoblastoma (Glioblastoma, Retinal) 11/2015
1	Neoplasm Metastasis (Metastasis) 09/2015
1	Nausea 09/2015

Drug/Important Bio-Agent (IBA)

21	AnthracyclinesIBA 11/2015 - 07/2004
10	Messenger RNA (mRNA)IBA 01/2019 - 03/2002
7	Proteins (Proteins, Gene)FDA Link 05/2016 - 03/2002
7	3-Iodobenzylguanidine (Iobenguane)IBA 11/2015 - 08/2003
5	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2015 - 10/2009
4	BL1521IBA 02/2006 - 10/2004
4	Histone Deacetylase InhibitorsIBA 02/2006 - 10/2004
3	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 02/2006
3	Gemcitabine FDA Link 06/2012 - 01/2006
3	FenretinideIBA 09/2011 - 05/2008
3	Epirubicin (Ellence)FDA LinkGeneric 07/2010 - 03/2010
3	cyclopentenyl cytosineIBA 01/2006 - 09/2002
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 01/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 06/2012
2	Adrenergic Agents (Adrenergic Drugs)IBA 01/2019 - 11/2012
2	Histones (Histone)IBA 01/2017 - 10/2004
2	Daunorubicin (Cerubidine)FDA LinkGeneric 11/2015 - 07/2010
2	Phosphotransferases (Kinase)IBA 10/2013 - 04/2008
2	SurvivinIBA 03/2012 - 10/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2011 - 03/2010
2	coenzyme Q10 (CoQ10)IBA 09/2011 - 06/2011
2	Dexrazoxane (Zinecard)FDA LinkGeneric 06/2011 - 01/2011
2	Cardiotonic Agents (Cardiac Stimulants)IBA 06/2011 - 05/2007
2	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 09/2009 - 03/2009
2	Cyclin D1IBA 04/2008 - 03/2003
2	CTP synthetaseIBA 01/2006 - 09/2002
2	Histone Deacetylases (Histone Deacetylase)IBA 10/2005 - 10/2004
1	trametinibIBA 01/2023
1	PlatinumIBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	N- propyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (PPTP)IBA 01/2021
1	dimethylaniline monooxygenase (N-oxide forming) (flavin-containing monooxygenase)IBA 01/2019
1	Polycomb Repressive Complex 2IBA 01/2017
1	CatecholaminesIBA 01/2017
1	Lysine (L-Lysine)FDA Link 01/2017
1	MethyltransferasesIBA 01/2017
1	GSK-2816126IBA 01/2017
1	Histone MethyltransferasesIBA 01/2017
1	venetoclaxIBA 05/2016
1	Apoptosis Regulatory ProteinsIBA 05/2016
1	Complement System Proteins (Complement)IBA 01/2016
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 11/2015
1	Cyclin-Dependent Kinase 2IBA 11/2015
1	4- (2,6- dichlorobenzoylamino)- 1H- pyrazole- 3- carboxylic acid piperidin-4-ylamideIBA 11/2015
1	NucleophosminIBA 11/2015
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 11/2015
1	Topotecan (Hycamtin)FDA LinkGeneric 11/2015
1	Heparin (Liquaemin)FDA LinkGeneric 09/2015
1	Ethanol (Ethyl Alcohol)IBA 09/2015
1	Prednisolone (Predate)FDA LinkGeneric 04/2015
1	DNA-Activated Protein KinaseIBA 01/2015

Therapy/Procedure

25	Therapeutics 01/2023 - 08/2003
13	Drug Therapy (Chemotherapy) 01/2022 - 10/2004
10	Radiotherapy 01/2019 - 01/2007
7	Aftercare (After-Treatment) 01/2016 - 06/2005
3	Minimally Invasive Surgical Procedures 01/2015 - 03/2010
2	Brachytherapy 10/2017 - 09/2016
2	Induction Chemotherapy 09/2016 - 12/2013
2	Antineoplastic Protocols 11/2015 - 09/2015
1	Investigational Therapies (Experimental Therapy) 01/2021
1	Blood Component Removal (Apheresis) 01/2019
1	Secondary Prevention 11/2016
1	Combined Modality Therapy 11/2015
1	Central Venous Catheters 09/2015
1	Stem Cell Transplantation 08/2015